OZEM Roundhill Investments - GLP-1 & Weight Loss ETF
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| OZEM | — | — | — | — | — | — |
| Equity average (4748 funds) | -5.3% | -6.8% | +27090.2% | +22162.3% | +27.3% | +2.9% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$0 net.
No open-market insider buys in the holdings in the last 90 days.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly & Co | 15.40% |
| 2 | NVO Novo Nordisk A/S | 11.71% |
| 3 | PFE Pfizer Inc | 7.65% |
| 4 | KLRA Kailera Therapeutics Inc | 5.88% |
| 5 | 1093.HK CSPC Pharmaceutical Group Ltd | 5.37% |
| 6 | 4519.T Chugai Pharmaceutical Co Ltd | 5.16% |
| 7 | AMGN Amgen Inc | 4.77% |
| 8 | VKTX Viking Therapeutics Inc | 4.56% |
| 9 | AZN AstraZeneca PLC | 4.25% |
| 10 | 128940.KS Hanmi Pharm Co Ltd | 4.11% |
| 11 | ROP.SW Roche Holding AG | 3.57% |
| 12 | ZEAL.CO Zealand Pharma A/S | 3.36% |
| 13 | 1276.HK Jiangsu Hengrui Pharmaceuticals Co Ltd | 2.85% |
| 14 | 3692.HK Hansoh Pharmaceutical Group Co Ltd | 2.83% |
| 15 | 3933.HK United Laboratories International Holdings Ltd/The | 2.77% |
| 16 | 1672.HK Ascletis Pharma Inc | 2.51% |
| 17 | 1801.HK Innovent Biologics Inc | 2.17% |
| 18 | GUBRA.CO Gubra A/S | 2.10% |
| 19 | GILD Gilead Sciences Inc | 2.04% |
| 20 | MBX MBX Biosciences Inc | 1.91% |
| 21 | RYTM Rhythm Pharmaceuticals Inc | 1.67% |
| 22 | GPCR Structure Therapeutics Inc | 1.54% |
| 23 | 4507.T Shionogi & Co Ltd | 1.40% |
| 24 | OZEM Cash & Other | 0.31% |
| 25 | FGXXX First American Government Obligations Fund 12/01/2031 | 0.30% |
| 26 | WVE Wave Life Sciences Inc | 0.24% |
| 27 | CHF SWISS FRANC | -0.45% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 30, 2025 | $0.4099 |
| Dec 30, 2024 | $0.0531 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in OZEM in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 18, 2026. This is historical data, not investment advice. Report a data error
